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INTRODUCTION 
Globally over 100 million people are affected by heart 
valve (HV) related diseases and 300,000 HV 
replacements are required annually (Kheradvar et al., 
2015). While HV replacement is a common procedure for 
adult patients, the inability of mechanical or bioprosthetic 
HVs to grow makes replacement surgery the final choice 
for paediatric patients, as multiple revision surgeries are 
often required. Tissue engineered heart valves (TEHVs) 
are the new paradigm and promise integration with the 
native vasculature, thereby facilitating growth and 
remodelling in vivo. This could eliminate paediatric 
patients’ need for revision surgeries. 
The TE approach we are interested in combines 
autologous cells with a fibrin-collagen-
glycosaminoglycan scaffold (Brougham et al., 2017, 
2015), and this construct is subsequently conditioned 
using a bioreactor. The bioreactor simulates the 
mechanical action of the heart, encouraging the 
directional proliferation of cells and the development of 
a biomimetic extracellular matrix. While many HV 
bioreactors have been developed, the ideal set up and 
conditioning regime to create a fully functional TEHV 
remains unknown. Therefore, the long term goal of this 
project is create a TEHV from the previously developed 
scaffolds (Brougham et al., 2017, 2015) suitable for in 
vivo trials. The initial project aim was to design a 
bioreactor that was capable of conditioning HVs using a 
range of parameters. 
 
DESIGN REQUIREMENTS 
The design requirements of the bioreactor included the 
ability to mimic both an adult and a neonate heart (heart 
rates 30 to 200 bpm, flow through the HV of 25 to 100 
ml/beat and a pressure drop of 13 to 25 mmHg across the 
valve). The bioreactor must be fabricated from non-
cytotoxic materials and be easy to sterilise (using 
ethylene oxide and/or autoclaving). It must facilitate gas 
exchange and media exchange while being housed inside 
an incubator and must remain sterile throughout the 
culture period. The delivery of the HV into the bioreactor 
must be accomplished using aseptic technique, the valve 
must be suitably fixed in place and be visible throughout 
the culture period. These design requirements were met 
in the proposed concept (Figure 1). 
 
DESIGN CONCEPT 
The bioreactor houses the HV in a central position 
between the pulmonary (3) and ventricular (2) chambers. 
Media is pumped through the valve by the displacement 
of a silicone membrane (f) and secured in a stainless steel 
base (1). This is achieved using a magnetic actuator, 
controlled using Labview. Silicone tubing will allow 
displaced media to circulate between polypropylene 
connectors (a) and (b), while a peristaltic pump will 
pump media between connectors (c) and (d). The main 
body (2, 3) and lid (4) of the bioreactor will be fabricated 
from PMMA with the design of the lid allowing clear 
observation of the HV leaflets. A compliance chamber 
will be attached to connector (e) to simulate arterial 
expansion and a syringe filter to promote gas exchange. 
  
Figure 1 Bioreactor design showing a heart valve in red. 
Bioreactor contains a base (1), ventricular chamber (2), 
pulmonary chamber (3), lid (4), heart valve support (5), 
connectors (a, b, c, d, and e) and silicone membrane (f). 
 
DISCUSSION 
This bioreactor design is loosely based on the conceptual 
design proposed by Hoerstrup et al. (2000), and uses 
elements from the bioreactor designed by Moreira et al. 
(2014). However, unlike those designs, here the 
ventricular chamber acts as a nozzle to direct the flow 
towards the HV. Operating parameters will be validated 
using a mechanical HV and measuring the pressure drop 
across the valve using pressure transducers. A flow 
sensor will measure the shear flow through the HV. 
Additionally, cytotoxicity tests are required to validate 
the choice of materials while sterility tests are required to 
validate its operating conditions. In time, this bioreactor 
will be employed to condition TEHVs using a variety of 
conditioning regimes. 
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